Cocrystal Pharma Inc.
Cocrystal Pharma, Inc. (Nasdaq: COCP) is a clinical-stage company developing novel, potent, broad-spectrum antiviral therapeutics to combat some of the most serious diseases facing humanity: coronaviruses (including SARS-CoV-2 and variants), pandemic and seasonal influenza, and noroviruses. Cocrystal employs unique structure-based technologies and Nobel Prize-winning expertise to create first- and best-in-class antiviral drugs with high barriers to resistance.
IR Website: https://ir.cocrystalpharma.com/
Headquarters: Bothell, WA
Content provided by Cocrystal Pharma on 3/6/22.